Hualong One
Hualong One (also known as HPR1000) is a third-generation pressurized water nuclear reactor technology, developed by the China General Nuclear Power Group (CGN) and the China National Nuclear Corporation (CNNC). The design is based on the earlier CPR-1000 platform, with enhancements to meet the latest international safety requirements.
History[edit | edit source]
The development of Hualong One began in 1990s as part of China's aim to create a standardized design for widespread deployment while reducing reliance on foreign technology. The design was finalized in 2014, and the first units began construction in 2015.
Design[edit | edit source]
Hualong One is a three-loop design with a 177 fuel assembly core. It has active and passive safety systems, including a double containment shell for improved safety. The design life of the reactor is 60 years, and it has a thermal efficiency of approximately 34.5%.
Deployment[edit | edit source]
As of 2021, Hualong One reactors are under construction or planned in several countries, including China, United Kingdom, Argentina, and Pakistan. The first Hualong One reactor to begin operation was Unit 5 of the Fuqing Nuclear Power Plant in China, which was connected to the grid in November 2020.
International Cooperation[edit | edit source]
China has been actively promoting Hualong One in international markets as part of its Belt and Road Initiative. In 2016, the United Kingdom approved the construction of a Hualong One reactor at the Bradwell nuclear power site.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD